Skip to main content

Advertisement

ADVERTISEMENT

Videos

Multidisciplinary Team Approach to CLI Treatment and Limb Salvage
Videos
02/04/2020
Paul Michael, MD, and Richard Neville, MD, discuss how to work across disciplines to help improve outcomes for patients with CLI.
Paul Michael, MD, and Richard Neville, MD, discuss how to work across disciplines to help improve outcomes for patients with CLI.
Paul Michael, MD, and Richard...
02/04/2020
Vascular Disease Management
Pave-and-Crack Technique Update at Seven Years
Meeting Exclusives
01/30/2020
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to...
01/30/2020
Vascular Disease Management
A Word of Warning on Lysis Therapy
Meeting Exclusives
01/30/2020
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed...
01/30/2020
Vascular Disease Management
‘Incredible Efficacy’ of DES Treatment of Long BTK Lesions
Presentation
01/30/2020
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn...
01/30/2020
Vascular Disease Management
DETOUR Into Long Lesions: A Viable Alternative to Open Fem-Pop Surgery
Meeting Exclusives
01/30/2020
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed...
01/30/2020
Vascular Disease Management
LINC 2020 Session: Latest Insights on the Safety and Efficacy of Drug-Coated Devices
Videos
01/30/2020
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill...
01/30/2020
Vascular Disease Management
Two-Year Data on Percutaneous Deep Vein Arterialization: Findings From the ALPS Registry
Meeting Exclusives
01/29/2020
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
The First 24-Month Data Release on the BTK Global Real-World Registry of the Lutonix DCB
Meeting Exclusives
01/29/2020
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix...
01/29/2020
Vascular Disease Management
A Bright Future for Laser Atherectomy?
Meeting Exclusives
01/29/2020
(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who...
(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
Lutonix BTK Trial 12-Month Data Released
Meeting Exclusives
01/29/2020
(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the...
(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management

Advertisement

Advertisement

Advertisement